title: Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer?
authors.affiliation: Department of Oncology, Chelsea and Westminster Hospital, London, United Kingdom.
authors.forename: Mark
authors.initials: M
authors.lastname: Bower
authors.forename: Danish
authors.initials: D
authors.lastname: Mazhar
authors.forename: Justin
authors.initials: J
authors.lastname: Stebbing
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D023241:Antiretroviral Therapy, Highly Active; D001932:Brain Neoplasms / Q000821:virology; D018791:CD4 Lymphocyte Count; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000821:virology; D009361:Neoplasm Invasiveness; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000150:complications; D012514:Sarcoma, Kaposi / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000821:virology*; D002578:Uterine Cervical Dysplasia / Q000821:virology